Home › Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals
 

Keywords :   


Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals

2015-08-30 19:41:11| Biotech - Topix.net

's stock had its "buy" rating restated by research analysts at Canaccord Genuity in a research report issued on Wednesday, Market Beat Ratings reports. They presently have a $700.00 price target on the biopharmaceutical company's stock, up from their previous price target of $600.00.

Tags: buy rating pharmaceuticals reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Wind Speed Probabilities Number 5
02.11Tropical Storm Lane Forecast Advisory Number 5
02.11Tropical Storm Lane Public Advisory Number 5
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Forecast Discussion Number 3
02.11Subtropical Storm Patty Wind Speed Probabilities Number 3
More »